Pay in 4 interest-free payments of $6.23 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
When to Discuss GLP-1 Eligibility With Your Provider If your BMI exceeds 27 with weight-related comorbidities or reaches 30 regardless of comorbidities, GLP-1 may warrant discussion with your primary care or weight management provider
22.5% mean weight loss with FDA-approved 15mg tirzepatide over 72 weeks (directly applies to Ro-prescribed Zepbound): nejm.org/doi/full/10.1056/NEJMoa2206038 CDC Adult Obesity Facts (41.9% US prevalence per NHANES 2017March 2020): cdc.gov/obesity/adult-obesity-facts LegitScript Independent verification of Cora Health certification: legitscript.com/websites/?checker_keywords=trycora.io Pharmacy Compounding Accreditation Board (PCAB) accreditation framework for compounding pharmacies
For venture investors, GLP-1 therapies also represent more than a healthcare trend
Summary: Mixing retatrutide with GHK-Cu is not supported by any published clinical evidence, pharmacokinetic data, or regulatory guidance, and carries significant unknown risks
What type of products can include this ingredient?+
US$ 23.02
US$ 28.23
US$ 23.23
US$ 20.87
US$ 25.37
US$ 29.75
US$ 27.37
US$ 22.32
US$ 29.62
US$ 25.86
